Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 5

    1.

    Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia.

    Maki KC, Lawless AL, Kelley KM, Dicklin MR, Kaden VN, Schild AL, Rains TM, Marshall JW.

    J Cardiovasc Pharmacol. 2011 Apr;57(4):489-94.

    PMID:
    21297494
    [PubMed - indexed for MEDLINE]
    2.

    The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia.

    Krysiak R, Okopien B.

    J Cardiovasc Pharmacol. 2011 Apr;57(4):505-12.

    PMID:
    21297492
    [PubMed - indexed for MEDLINE]
    3.

    The effect of simvastatin on lymphocyte secretory function in patients with impaired fasting glucose.

    Krysiak R, Okopien B.

    J Cardiovasc Pharmacol. 2010 Nov;56(5):491-7.

    PMID:
    21108528
    [PubMed - indexed for MEDLINE]
    4.

    Markers of cholesterol absorption and synthesis predict the low-density lipoprotein cholesterol response to atorvastatin.

    Hoenig MR, Walker PJ, Gurnsey C, Beadle K, Johnson L.

    J Cardiovasc Pharmacol. 2010 Oct;56(4):396-401.

    PMID:
    20625310
    [PubMed - indexed for MEDLINE]
    5.

    Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin/ezetimibe coadministration.

    Araujo DB, Bertolami MC, Ferreira WP, Abdalla DS, Faludi AA, Nakamura Y, Bricharello LP.

    J Cardiovasc Pharmacol. 2010 Jan;55(1):1-5.

    PMID:
    19770669
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk